ArticleBMC cancer2024

Identification of dimethyl 2,2'-((methylenebis(2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)-6,1phenylene))bis(oxy))diacetate (TAJ4) as antagonist of NEK-Family: a future for potential drug discovery.

Mubashir Aziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.